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Abstract 
Dissociative disorders are frequent comorbid conditions of other mental disorders. Yet, there 
is controversy about their clinical relevance, and little systematic research has been done on 
how they influence global functioning. Outpatients and day care patients (N=160) of several 
psychiatric units in Switzerland were assessed with the Structured Clinical Interview for 
DSM-IV Axis I Disorders, Structured Clinical Interview for DSM-IV Dissociative Disorders, 
Global Assessment of Functioning Scale, and World Health Organization Disability 
Assessment Schedule-II. The association between subjects with a dissociative disorder 
(N=30) and functional impairment after accounting for non-dissociative axis I disorders was 
evaluated by linear regression models. We found a proportion of 18.8% dissociative disorders 
(dissociative amnesia=0%, dissociative fugue=0.6%, depersonalization disorder=4.4%; 
dissociative identity disorder=7.5%, dissociative disorder-not-otherwise-specified=6.3%) 
across treatment settings. Adjusted for other axis I disorders, subjects with a comorbid 
dissociative identity disorder or dissociative disorder-not-otherwise-specified-I had a median 
global assessment of functioning score that was 0.86 and 0.88 times, respectively, the score of 
subjects without a comorbid dissociative disorder. These findings support the hypothesis that 
complex dissociative disorders, i.e., dissociative identity disorder and dissociative disorder-
not-otherwise-specified-I, contribute to functional impairment above and beyond the impact 
of co-existing non-dissociative axis I disorders, and that they qualify as “serious mental 
illness”. 
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1. Introduction 
According to a new definition proposed by Spiegel and colleagues for DSM-V, 
dissociation is a “disruption of and/or discontinuity in the normal, subjective integration of 
one or more aspects of psychological functioning, including - but not limited to - memory, 
identity, consciousness, perception, and motor control. In essence, aspects of 
psychobiological functioning that should be associated, coordinated, and/or linked are not… 
Dissociative symptoms are characterized by (a) unbidden and unpleasant intrusions into 
awareness and behavior, with accompanying losses of continuity in subjective experience: 
(i.e., ‘positive’ dissociative symptoms); and/or (b) an inability to access information or to 
control mental functions that normally are readily amenable to access or control: (i.e., 
‘negative’ dissociative symptoms’).” (Spiegel et al., 2011, p. 826) 
The Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) lists four 
diagnoses under the category dissociative disorders (DD). Dissociative amnesia (DA) refers 
to episodes of a serious subjective loss of memory, often occurring in the context of stressful 
or traumatic life events. In a dissociative fugue (DF), individuals abruptly travel away from 
home and show a partial or complete adoption of a new identity and an inability to remember 
important aspects of their life. Both of these types of DDs are considered as transient 
disorders with acute onset and often spontaneous recovery (Ross, 2009). Depersonalization 
disorder (DPD) is marked by chronic or recurrent feelings of unreality or strangeness 
regarding one’s body, self, behavior, or environment (Simeon et al., 2003). Subjects with a 
DPD characteristically report that when they experience depersonalization/derealization they 
have problems in certain activities such as following a conversation or keeping focused on a 
task. Individuals with a dissociative identity disorder (DID) experience themselves as having 
more than one distinct identity or personality, which either share or compete for control over 
behavior. Some identities have a certain lack of conscious awareness of others. As a 
consequence of switching between different personality states, persons with a DID may have 
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recurrent amnesia in daily life lasting for minutes, hours or even days, experienced as “time 
loss”. Dissociative disorder-not-otherwise-specified (DDNOS) refers to various forms of 
dissociation that are not fully covered by any of the specific DDs. Some authors classify cases 
that are similar to DID but lacking insufficient criteria for a full DID diagnosis (e.g. when 
there is no amnesia between distinct identities) as DDNOS - category I (DDNOS-I) 
(Steinberg, 1994). DID and DDNOS-I have been conceptualized as complex DDs, because 
they are characterized by recurrent dissociative intrusions into every aspect of executive 
functioning and sense of self, that distinct them from 'simpler' DDs, i.e., DA, DF, and DPD 
(Dell, 2006; 2009). 
Numerous studies in the last two decades have revealed that DDs are relatively frequent 
conditions in psychiatric populations. The median outpatient prevalence is 8.6% and the 
median inpatient prevalence is 10.2%, according to studies from North America, Europe and 
Asia (overview in (Dell, 2009)). DDs are often comorbid conditions, occurring particularly in 
conjunction with anxiety, mood, and personality disorders (Dell, 1998; Johnson et al., 2006; 
Rodewald et al., 2011). Despite their frequency of occurrence in psychiatric populations, the 
clinical relevance of DDs is unclear. In clinical practice, they are rarely diagnosed and rarely 
considered in treatment planning (Foote et al., 2006; Ginzburg et al., 2010). Some clinicians 
even question the diagnostic validity of certain types of DDs (Pope et al., 1999; Ginzburg et 
al., 2010). One approach to evaluating the clinical relevance of DDs is to determine their 
impact on daily functioning. Some clinicians experienced in the treatment of DDs have noted 
that many of their patients, particularly with DID and DDNOS-I, have both considerable 
comorbidity and low levels of functioning (Kluft, 1999; Van der Hart et al., 2006).  This is in 
line with previous studies that found a high comorbidity and an extensive psychiatric 
treatment history in DID subjects (Putnam et al., 1986; Ross et al., 1989; Boon & Draijer, 
1993; Ellason et al., 1996; Dell, 1998), as well as a strong association with self-harming 
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behavior and suicidality (Foote et al., 2008). However, there is a need for systematic research 
on the functional impact of DDs.  
In this study, we sought to determine whether DDs are associated with impaired 
functioning in daily life. We expected to find lower global functioning and higher disability 
scores in psychiatric subjects with a comorbid DD compared to subjects with other mental 
disorders but without a DD. To test this hypothesis, we assessed dissociative and non-
dissociative psychopathology through structured interviews in a sample of psychiatric 
outpatients and day care patients. 
2. Methods 
2.1. Subjects and Procedure 
All subjects between 18 and 65 years with sufficient fluency in the German language 
who were in treatment (three and more sessions) during 1/2009 to 12/2010 were eligible for 
participation. Subjects were recruited from two public psychiatric outpatients units, one 
private practice, and two psychiatric day care units, all located in the counties of St. Gallen or 
Zurich in Switzerland. Exclusion criteria included acute psychosis, acute suicidal ideation, 
substance abuse with acute intoxication or withdrawal, mental retardation, and psychiatric 
disorders due to an underlying medical condition. 
Enrolled subjects were assessed by trained interviewers (with a B.Sc. or a M.Sc. 
degree). The study protocol was approved by the institutional review board of the county of 
St. Gallen, Switzerland. All subjects provided written informed consent. Study participation 
was compensated by CHF 100 (equivalent to approximately US$ 100). Sociodemographic 
data and axis I diagnoses are presented in Table 1. 
2.2. Measurements 
Diagnoses were ascertained with the Structured Clinical Interview for DSM-IV Axis I 
Disorders [SCID-I (First et al., 1997)] and the Structured Clinical Interview for DSM-IV 
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Dissociative Disorders [SCID-D-R, (Steinberg, 1994; Gast et al., 2000)]. The SCID-D-R is a 
semi-structured interview for the diagnosis of a DSM-IV DD. The categorical diagnosis of a 
DD is based on the dimensional assessment of five dissociative symptoms ‘amnesia’, 
‘depersonalization’, ‘derealization’, ‘identity confusion’, and ‘identity alteration’ on a 4-
point-Likert scale (1=none, 2=mild, 3=moderate, 4=severe). The interviewer rates the severity 
of each of the five dissociative symptoms according to specific behaviors and experiences 
reported by the patient as well as the observation of dissociative symptoms during the 
interview. Reliability and validity of the SCID-D-R is good to excellent (Steinberg, 1989-
1992). 
Global level of functioning was measured by the Global Assessment of Functioning 
Scale [GAF (Hilsenroth et al., 2000)], a single-item expert rating scale for evaluating current 
overall psychological, social, and professional functioning on a continuum from 
psychological sickness to health. The GAF scale values range from 1 to 100, representing the 
hypothetically sickest person to the hypothetically healthiest. A GAF score above 70 
represents no more than minimal or transient symptoms without relevant impairment in social 
or professional functioning. A score between 61 and 70 designates mild psychopathology or 
mild impairment, between 51 and 60 moderate symptoms or functional impairment, and 
below 51 severe psychopathology and disability. Functional impairment due to physical 
disorders is disregarded in the evaluation of the GAF score. The GAF exhibits very high 
interrater reliability (intraclass correlation coefficient=0.92, Spearman-Brown corrected) 
(Hilsenroth et al., 2000).  
Global level of disability was ascertained by the interviewer-administered version of the 
World Health Organization (WHO) Disability Assessment Schedule II (WHODAS II) (World 
Health Organization, 2000) that contains 36 questions covering six domains of assessment. 
These are based on the International Classification of Functioning, Disability and Health 
(World Health Organization, 2001) that classifies impairments in body functions and 
6 
 
structure; activity limitations; participation restrictions; and environmental factors caused by 
mental or physical illness. A 5-point rating scale was used; the subject rated the level of 
difficulty experienced as none, mild, moderate, severe, or extreme with higher scores 
reflecting higher functional impairment. According to the WHODAS II manual, the 
interviewers merely recorded subject’s ratings. Beside the summary score, the WHODAS II 
provides domain scores for the life areas ‘understanding and communicating’ (cognition); 
‘getting around’ (mobility); ‘self-care’ (attending to one’s hygiene, dressing, eating and 
staying alone); ‘getting along with people’ (interpersonal interactions); ‘life activities’ 
(domestic responsibilities, work); and ‘participation in society’ (joining in community 
activities). The WHODAS II has demonstrated sound psychometric properties (Chopra et al., 
2004; McKibbin et al., 2004; Kutlay et al., 2011); interrater reliability for the summary score 
was found to be high (intraclass correlation coefficient=0.93, 95% CI: 0.91–0.95). 
2.3. Data Analysis 
Inter-rater reliability for the diagnosis of the five DSM-IV DDs according to the SCID-
D-R between the assessors and the first author was calculated as Fleiss kappa (Fleiss et al., 
1969) including an adjusted bootstrap confidence interval, based on M = 1000 bootstrap 
replications, on all subjects who permitted videotaping their SCID-D-R interview (N=84). 
Descriptive statistics included frequencies and percentages for categorical data and, 
since our continuous variables were all not normally distributed, median and interquartile 
range (IQR) for continuous data. Fisher’s exact tests were used to compare categorical data 
between groups. The Kruskal-Wallis test was used to compare continuous data between 
groups. The Mann-Whitney rank-sum test was used to compare continuous data between two 
groups. P-values of post hoc pairwise comparisons were Bonferroni-Holm corrected. The 
between-groups effect was quantified using the Hodges-Lehmann estimator, which is the 
location estimate that is consistent with the Mann-Whitney test (Hollander & Wolfe, 1999). 
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This estimator is the median of all possible differences in outcomes between a subject in the 
first and a subject in the second group and does not necessarily equal the difference of the 
group medians. Correlations between continuous variables were analyzed using Spearman’s 
rank correlation. A confidence interval for the correlation coefficient was computed using 
Fisher's z-transformation. For proportions, we computed confidence intervals according to 
Wilson's method. All confidence intervals were computed at a confidence level of 95%, all 
tests were applied two-tailed, and a significance level of 0.05 was used. 
To generate linear regression models we proceeded as follows: Since when modeling 
the response variables, especially the subscores, residuals were not sufficiently normally 
distributed, especially for very small values and specifically values of 0, we transformed them 
in order to better meet the assumptions for the tests on the parameters in a linear regression 
model. We set every value ≤4 to the value of 4 for all responses, where the constant 4 was 
chosen such that the histograms of the log-transformed response variables looked 
approximately symmetric. Then, we took the logarithm of this modified variable. In order to 
get parameter estimates on the original scale we re-transformed initial estimates for the log-
response by exponentiating them. Due to truncation at 4, conclusions should not be drawn for 
response values below, say, 10. However, this did not apply to any subject in the study. 
Profile likelihood confidence intervals were computed for the parameter estimates. 
3. Results 
3.1. Enrollment of Subjects 
The records of 374 subject candidates who fulfilled the inclusion criteria during the 
study period 1/2009 to 12/2010 were reviewed. Of these, 62 (16.6%) could not be enrolled 
due to the presence of an exclusion criterion (mental retardation 25, acute psychosis 23, 
underlying medical condition 8, acute suicidal ideation 3, intoxication or withdrawal 3).  The 
remaining 312 subject candidates were invited to participate.  Of these 136 (43.6%) declined, 
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yielding a pool of 176 recruited subjects. Recruited subjects did not significantly differ from 
decliners regarding gender (60.8% vs. 56.6% females, p=0.5), age (median=34.0 vs. 41.5 
years, p=0.05), and nationality (81.3% vs. 82.4% Swiss, p=0.9), suggesting representativeness 
of our sample. Finally, data from 16 recruited subjects (9.1% of the 176) were excluded from 
the data analysis due to incomplete participation or doubtful validity of the results (e.g., 
suspected dissimulation or difficulties in understanding the questions) as judged by the 
interviewer after discussion with the first author, yielding a final sample size of 160 subjects. 
3.2. Frequency and Comorbidity of Dissociative Disorders 
Among the final sample of 160 subjects, 30 subjects (18.8%; 95% CI=13.5%-25.5%) 
were diagnosed with a DD (0 DA [0%]; 1 DF [0.6%]; 7 DPD [4.4%]; 12 DID [7.5%]; 10 
DDNOS-I [6.3%]). Twenty two of the total 30 subjects diagnosed with a DD (73.3%), 
received a diagnosis of a complex DD (i.e., DID, DDNOS-I). Inter-rater reliability for the 
diagnosis of the five DSM-IV dissociative disorders according to the SCID-D-R was high 
(Fleiss’ kappa = 0.90, 95% CI = 0.73 – 1.00, n = 84). The proportion of DDs did not differ 
significantly between treatment settings (p=0.5). Subjects with a DD were more often females 
than Non-DD subjects. DD subjects had significant more comorbid axis I disorders 
(Range=1-6; Median=3) compared to Non-DD subjects (Range=0-7; Median=1; p<0.001). 
DDNOS-I and DID subjects had a higher total number of comorbid axis I disorders and more 
comorbid anxiety disorders than Non-DD subjects. DDNOS-I subjects had more comorbid 
affective disorders than DPD and Non-DD subjects (Table 1).  
3.3. Measures of Global Functioning and Disability 
Descriptive GAF and WHODAS II data in subjects with a DD and subjects without a 
DD are presented in Table 2. As seen in Figure 1, the median GAF score differed significantly 
between Non-DD, DPD, DDNOS-I, and DID subjects (Kruskal-Wallis H=13.72, df=1, 
p<0.001). DDNOS-I subjects had a significantly lower median GAF score than DPD 
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(Hodges-Lehmann estimator=15.0; 95% CI=8.0-23.0; p=0.001) and Non-DD subjects 
(Hodges-Lehmann estimator=11.0; 95% CI=5.0-17.0; p=0.002). DID subjects had a 
significantly lower median GAF score than DPD (Hodges-Lehmann estimator=18.0; 95% 
CI=14.0-24.0; p=0.001) and Non-DD subjects (Hodges-Lehmann estimator=13.0; 95% 
CI=7.0-19.0; p<0.001). 
 The median WHODAS II Summary Score also differed significantly among Non-DD, 
DPD, DDNOS-I, and DID subjects (p=0.008); p-values for post-hoc pairwise comparisons, 
however, did not survive correction for multiple tests (ps>0.06). The moderate correlation 
between GAF and WHODAS II Summary Scores in the total sample (Spearman correlation=-
0.42; 95% CI=-0.54--0.29; p<0.001) partially supports the criterion validity of the two scales 
for measuring global functioning (GAF) and disability (WHODAS II). 
Adjusted for gender, age, and the presence of Non-DD axis I disorder categories 
(Table 3), subjects with a DDNOS-I or DID had a median GAF score that was 0.88 
(95% CI=0.78-0.98; p=0.03) and 0.86 (95% CI=0.76-0.96; p=0.01) times the score of subjects 
without a DD. The presence of a DPD had no significant influence on the GAF score 
(p=0.21).  Neither DPD, DDNOS-I, nor DID had a significant influence on the WHODAS 
Summary Scores after adjusting for gender, age, and the presence of Non-DD axis I disorder 
categories (ps>0.33). In secondary analyses, none of the WHODAS domain scores was 
significantly influenced by DPD, DDNOS-I, or DID after adjusting for multiple tests (data not 
presented). 
4. Discussion 
The aim of our study was to investigate whether DDs are associated with global 
functioning and disability among psychiatric outpatients and day care patients. Our results 
suggest that DID and DDNOS-I (i.e., complex DDs), but not DPD contribute to functional 
impairment above and beyond the impact of other non-dissociative axis I disorders. 
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The proportion of 18.8% DD that we ascertained in our sample is comparable to 
previous findings in corresponding treatment settings in the US (Graves, 1989; Lussier et al., 
1997; Foote et al., 2006) , Turkey (Sar et al., 2000), Finland (Lipsanen et al., 2004), and 
China (Xiao et al., 2006), thereby supporting the cross-cultural validity of DDs. All of our DD 
subjects had at least 1, and on average 3, comorbid axis I disorders. In correspondence with 
other studies (Johnson et al., 2006; Rodewald et al., 2011), the most frequent comorbid 
conditions were affective and anxiety disorders. 
In line with a previous general population study by Johnson et al. (Johnson et al., 2006) 
in adults, we observed a significant relationship between the presence of a DD, specifically 
DID and DDNOS-I, and lower global functioning as measured by the GAF. Our study 
improved upon the findings of Johnson et al., by employing rigorous diagnostic 
characterization, including an in-person SCID-D-R interview for every subject enrolled. In 
contrast, Johnson et al. first administered a self-report screening instrument, viz., the 
Dissociative Experience Scale-Taxon [DES-T (Waller et al., 1996)], followed in subjects who 
passed the screening by selected questions from the SCID-D-R. However, several authors 
(Friedl et al., 2000; Foote et al., 2006; Rodewald et al., 2006) have questioned the validity of 
the application of a preliminary self-rating cut-off score prior to a diagnostic DD interview 
out of the concern that this practice leads to false-negative cases. In addition, the interviews in 
the study of Johnson et al. were conducted by telephone, precluding the direct observation of 
dissociative signs as called for in the SCID-D-R. 
 The median GAF score of DID subjects in our sample (i.e., 41 out of a possible 100) 
was the same as the mean score found in the Johnson et al. study. We found a 7 point lower 
median GAF score (i.e., 44) in DDNOS-I subjects, and a 16 point higher median score (i.e., 
59) in DPD subjects compared to the corresponding mean score in the Johnson et al. study. 
This discrepancy might be explained by the difference in diagnostic techniques, by the 
different types of populations the samples were drawn from, by the different gender 
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distribution of the subjects with DD diagnoses, and/or by different forms of DDNOS 
diagnoses found in the two studies. We observed a 14% and 12% lower estimated GAF score 
in subjects with versus without a comorbid DID and DDNOS-I, respectively. This difference 
is of sufficient magnitude to be of clinical relevance. Moreover, the median GAF scores of 41 
and 44 we found for DID and DDNOS-I subjects, respectively, suggest that each of these 
disorders qualifies as a “serious mental illness” (Kessler et al., 2003) with respect to 
functional impairment. In contrast, no significant contribution to functional impairment was 
found for DPD subjects. This result suggests that dissociative problems involving memory 
and identity are more detrimental to functioning than are problems with depersonalization and 
derealization. These data provide evidence supporting the conceptualization of DID and 
DDNOS-I as being closely related complex DDs (Dell, 2009), which are distinctly more 
symptomatic and impairing than 'simpler' DDs. Not surprisingly, other strong predictors for 
lowered global functioning and disability in our sample were affective disorders, psychotic 
disorders, and anxiety disorders, which is in agreement with the findings from a European-
wide epidemiological study (Alonso et al., 2004). 
A possible reason for the non-significant result regarding the influence of DD on the 
WHODAS II Summary Score when adjusted for multiple tests and comorbid mental disorders 
is that the WHODAS II also covers disability in life activities that are strongly related to 
physical morbidity (e.g., “standing for long periods such as 30 minutes”), resulting in a 
contamination of the WHODAS II’s validity for measuring psychologically based disability. 
Moreover there might be a discrepancy between the clinician rating provided by the GAF and 
the self-rating provided by the WHODAS II. For example, the interviewer might be more 
inclined to rate higher functional impairment in subjects with a DD, whereas DD subjects 
themselves might be inclined to underreport disability. 
Several limitations need to be noted. First, the interviewers were not blinded regarding 
the presence of a DD when evaluating global functioning using the GAF. Second, physical 
12 
 
causes for disability that might have contaminated the WHODAS II ratings were not 
comprehensively assessed; nevertheless, the exclusion of all subjects who received disability 
benefits due to a physical disorder (N=6) did not substantially change our results (data not 
shown). Third, we did not collect data on treatment history; treatment might have an impact 
on the coping abilities of DD patients. Fourth, the generalization of our findings to all persons 
with a DD in the population is compromised by the fact that our sample consisted of 
psychiatric patients undergoing treatment. There may be relatively high functioning persons 
with a DID in the community with less health care utilization (Kluft, 1999). Fifth, we did not 
statistically control for the presence of axis II disorders, which may influence GAF and 
WHODAS-II scores. It is proposed, however, that axis I and axis II comorbidity might be an 
integral aspect of DID (Ellason et al., 1996). From this perspective, controlling for 
comorbidity may result in an underestimation of the association between DID and functional 
impairment. Sixth, our results may not apply to the dissociative disorders of movement and 
sensation according to the International Statistical Classification of Diseases and Related 
Health Problems 10th Revision (ICD-10) (World Health Organization, 2010), which are 
classified in DSM-IV under conversion disorders. Seventh, in DID subjects, the results of 
self-rating scales and interviews may be influenced by the specific dissociative part of the 
personality that was dominant at the time of the assessment. Finally, although our study did 
not include the measurement of self-harming behavior, this should be considered in future 
studies. 
Our data provide important clarification regarding the clinical relevance of DDs, 
especially when a DD is a complex DD (which was the case in 73% of patients with 
significant dissociative symptoms in this study). Given the substantial adverse impact on 
functioning, complex DDs must be regarded as severe mental illnesses that need to be 
addressed in treatment planning. This includes the careful consideration of comorbid 
dissociative pathology even when patients present for the treatment of non-dissociative 
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complaints. Specific therapeutic approaches that target the comorbid dissociative disorder 
may be useful in helping to remedy dysfunction and improving the treatment outcome of 
these patients. Such approaches may include the development of emotion regulation and 
grounding skills (Cloitre et al., 2002; Cloitre et al., 2010), cognitive-behavioral techniques 
(Hunter et al., 2003; Hunter et al., 2005), or work with the patient’s experience of identity 
confusion and alteration (Van der Hart et al., 2006; International Society for the Study of 
Trauma and Dissociation, 2011). 
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Higher scores represent higher functioning. 
 
Higher scores represent higher disability. 
Fig. 1. Boxplots of Global Assessment of Functioning scores (A) and WHO Disability Assessment Schedule II summary scores 
(B) in subjects without a dissociative disorder and subjects with a depersonalization disorder (N=7), dissociative disorder-not-
otherwise-specified-I (N=10), and dissociative identity disorder (N=12). Omnibus test on Global Assessment of Functioning 
scores: p<0.001, post hoc between group comparisons: DDNOS-I, DID<Non-DD, DPD, ps<0.05, Bonferroni-Holm corrected. 
Omnibus test on and WHO Disability Assessment Schedule II summary scores: p=0.008, post hoc between group comparisons 
not significant after correction for multiple testing. 
The bottom and top of the boxes represent the lower and upper quartiles, respectively; the line within the box represents the 
median; the whiskers extend to either the minimum or maximum observed value, or the point that is 1.5 box heights away from 
the lower quartile, whichever is larger. 
WHO: world health organization; Non-DD: no dissociative disorder; DPD: depersonalization disorder; DID: dissociative identity 
disorder; DDNOS-I: dissociative disorder-not-otherwise-specified-I 
 
 
 
Table  1 
Sociodemographics and Axis I Comorbidity of Subjects With a Dissociative Disorder (N=30) and Subjects Without a Dissociative Disorder (N=130) 
 
No dissociative disorder 
(N=130) 
Depersonalization 
disorder 
(N=7) 
Dissociative disorder-not-
otherwise-specified-I 
(N=10) 
Dissociative identity 
disorder 
(N=12)a 
Total 
(N=160) Analysis 
 N % N % N % N % N % 
Omnibus 
pb 
Pairwise 
comparisons 
(p<0.05)c 
Female 80 61.6 7 100.0 10 100.0 11 91.7 107 67.3 0.001 DID>Non-DDd 
Swiss nationality 97 74.6 5 71.4 8 80.0 5 41.7 115 71.9 0.11 - 
Primary source of income             
 Own earnings 34 26.1 1 14.3 1 10.0 2 16.7 38 23.8 0.71 - 
 Earnings of partner, parents, 
 or relatives 16 12.3 0 0.0 3 30.0 1 8.3 20 12.5 0.31 - 
 Retirement payments 3 2.3 0 0.0 0 0.0 0 0.0 3 1.9 1.00 - 
 Disability payments due to 
 a mental disorder 22 16.9 2 28.6 3 30.0 6 50.0 33 20.6 0.02 - 
 Disability payments due to 
 a physical disorder 5 3.8 0 0.0 0 0.0 1 8.3 6 3.8 0.71 - 
 Public welfare 30 23.1 3 42.9 2 20.0 1 8.3 36 22.5 0.40 - 
 Unemployment benefits 7 5.4 0 0.0 1 10.0 1 8.3 10 6.2 0.58 - 
 Other, e.g. savings 13 10.0 1 14.3 0 0 0 0 14 8.8 0.47 - 
Axis I Diagnoses             
 Affective disorders 59 45.4 1 14.3 9 90.0 8 66.7 78 48.8 0.005 DDNOS-I> Non-DD, DP 
 Psychotic disorders 5 3.8 0 0.0 0 0.0 0 0.0 5 3.1 1.00 - 
 Substance use disorders 10 7.7 2 28.6 1 10.0 4 36.4 17 10.7 0.01 - 
 Anxiety disorders 54 41.5 6 85.7 10 100.0 11 91.7e 81 50.9 <0.001 DDNOS-I, DID> Non-DD 
 Somatoform disorders 12 9.2 0 0.0 1 10.0 2 16.7e 15 9.4 0.59 - 
 Eating disorders 13 10.0 2 28.6 3 30.0 1 8.3e 19 11.9 0.10 - 
 Adjustment disorder 5 3.8 1 14.3 0 0.0 0 0.0 6 3.8 0.40 - 
 Median IQR Median IQR Median IQR Median IQR Median IQR 
Omnibus 
pb 
Pairwise 
comparisons 
(p<0.05)c 
Age (years) 34.5 19.0 27.0 4.0 30.5 18.3 31.5 21.3 32.0 19.5    0.05 - 
2 
 
Education (years) 12.0 3.0 12.0 3.0 13.5 4.3 13.5 2.8 12.0 3.0    0.36 - 
Number of axis I diagnoses 1.5 1.0 2.6 2.5 2.8 1.0 2.8 1.0 1.7 1.8 <0.001 DDNOS-I, DID> Non-DD 
a One subject with a dissociative identity disorder diagnosis reported to be intersex. 
b Fisher’s exact tests were used for comparing diagnostic groups on categorical variables; Kruskal-Wallis tests were used for continuous variables. 
c Fisher’s exact tests were used for post hoc pairwise comparisons of diagnostic groups on categorical variables; Mann-Whitney rank-sum tests were used for continuous variables; p-values are 
Bonferroni-Holm corrected. 
d Because there were only females with a DP and a DDNOS-I, tests could not be performed for these categories. 
e Data from one subject with a dissociative identity disorder diagnosis were not available. 
IQR: interquartile range; Non-DD: no dissociative disorder; DD: dissociative disorder; DPD: depersonalization disorder; DID: dissociative identity disorder; DDNOS-I: dissociative disorder-not-otherwise-
specified-I 
 
 
 
 
Table  2 
Global Assessment of Functioning Scores and WHO Disability Assessment Schedule II Summary and Dimensional Scores in Subjects With a Dissociative Disorder (N=30) and Subjects Without a 
Dissociative Disorder (N=130) 
 
No dissociative disorder 
(N=130) 
Depersonalization 
disorder 
(N=7) 
Dissociative disorder-not-
otherwise-specified-I 
(N=10) 
Dissociative identity 
disorder 
(N=12)a 
Total 
(N=160) Analysis 
 Median IQR Median IQR Median IQR Median IQR Median IQR 
Omnibus 
pa 
Pairwise 
comparisons 
(p<0.05)b 
Global Assessment of 
Functioning 54.00 14.00 59.00 4.50 44.00 4.50 41.00 4.75 53.00 16.00 <0.001 
DDNOS-I, DID< 
Non-DD, DP 
WHO Disability Assessment 
Schedule II 
            
 Summary 31.25 28.54 34.91 18.79 48.66 26.97 50.00 19.50 33.96 28.80 0.008 - 
 Understanding and 
 communicating 25.00 30.00 30.00 25.00 50.00 20.00 55.00 17.50 30.00 30.00 <0.001 
DDNOS-I, DID> 
Non-DD 
 Getting around 12.50 35.94 31.25 34.38 25.00 32.81 18.75 15.62 18.75 34.38 0.34 - 
 Self-care 10.00 20.00 20.00 10.00 30.00 37.50 35.00 17.50 10.00 20.00 <0.001 DID>Non-DD 
 Getting along with people 33.33 50.00 33.33 33.33 50.00 50.00 66.67 18.75 33.33 54.17 0.09 - 
 Life activities 40.00 50.00 60.71 53.93 65.36 26.07 70.00 53.04 42.86 51.43 0.02 - 
 Participation in Society 45.83 33.33 37.50 18.75 58.33 23.96 64.58 23.96 50.00 35.42 0.03 - 
a Kruskal-Wallis tests were used for comparing diagnostic groups on continuous variables. 
b Mann-Whitney rank-sum tests were used for post hoc pairwise comparisons of diagnostic groups; p-values are Bonferroni-Holm corrected 
IQR: interquartile range; Non-DD: no dissociative disorder; DD: dissociative disorder; DPD: depersonalization disorder; DID: dissociative identity disorder; DDNOS-I: dissociative disorder-not-otherwise-
specified-I 
 
 
Table 3 
Regression Analysis Summaries for Distinct Types of Dissociative Disorders, Other Axis-I Disorders and Sociodemographic 
Variables Predicting Global Assessment of Functioning Scores and WHO Disability Assessment Schedule II Summary Scores 
 Global Assessment of Functioning 
WHO Disability Assessment Schedule II 
Summary 
Variable B Exp(B) 
95% CI 
Exp(B) t p B Exp(B) 
95% CI 
Exp(B) t p 
Depersonalization 
Disorder  0.09 1.09 0.95-1.25 1.27   0.21  0.27 1.31 0.76-2.23 0.98   0.33 
Dissociative disorder-
not-otherwise-
specified-I -0.13   0.88 0.78-0.98 -2.25   0.03  0.07 1.07 0.68-1.68 0.29   0.77 
Dissociative Identity 
Disorder -0.16   0.86 0.76-0.96 -2.62   0.01  0.16 1.18 0.75-1.85 0.71   0.48 
AffectiveDisorder -0.10   0.91 0.86-0.96 -3.59 <0.001  0.61 1.84 1.49-2.29 5.62 <0.001 
PsychoticDisorder -0.47   0.63 0.54-0.73 -6.08 <0.001  0.68 1.98 1.10-3.58 2.29   0.02 
SubstanceDisorder -0.01   0.99 0.90-1.08 -0.28   0.78 -0.08   0.93 0.65-1.32 -0.43   0.67 
AnxietyDisorder -0.11   0.90 0.85-0.96 -3.47   0.001  0.33 1.39 1.10-1.75 2.78   0.01 
SomatoformDisorder -0.08   0.92 0.84-1.01 -1.84   0.07  0.06 1.06 0.75-1.51 0.35   0.73 
EatingDisorder -0.01   0.99 0.91-1.08 -0.19   0.85  0.02 1.02 0.74-1.41 0.13   0.90 
AdjustmentDisorder -0.01   0.99 0.86-1.14 -0.10   0.92  0.39 1.48 0.86-2.57 1.42   0.16 
Sex (female)  0.02 1.02 0.96-1.08 0.52   0.60  0.35 1.41 1.12-1.78 2.96   0.004 
Age  0.001 1.00 0.998-1.003 0.50   0.62  0.01 1.01 0.999-1.017 1.72   0.09 
 Radj2= .35 (N=157) Radj2= .33 (N=157) 
 
